Get Started

ADCT

NYSE ADC Therapeutics Ltd
Nov 3, 2026 · 7:29 AM ET LAST TRADE Market Closed

$1.55 ↑ +0.01 (+0.65%) Trading Up from the previous close of $1.54

YTD change
-56.09%
vs 20-day SMA
+1.01%
vs 200-day SMA
-37.25%

Price ranges

Previous day
$1.50 $1.68
open $1.58 close $1.54
-$0.04 (-2.53%)
Today
$0.00 $0.00
$1.55
Past week
$1.43 $1.70
from $1.51 now $1.55
+$0.04 (+2.65%)
Past month
$1.20 $1.87
from $1.23 now $1.55
+$0.32 (+26.02%)
This year
$0.78 $4.98
from $3.53 now $1.55
-$1.98 (-56.09%)

Price & Performance

-2.14 (-58.15%) / 6M

$0.7281$1.85$2.97$4.09May 4Aug 4Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 97.3% away from all-time highs of $56.59
  • ADCT is down 56% since the beginning of the year
  • ADCT is down 63% over the past 12 months
  • ADCT is up 26% over the past 1 month
  • 7% of all ADCT investors are betting against ADCT
  • Number of investors short ADCT has gone down 1% versus last month

ADCT reads not so good: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is -63.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.11
Earnings momentum +48.2% Quarterly EPS growth
Quarterly change +48.2%

Valuation

P/E ratio N/A
Enterprise value $137.2M
Beta 3.38

Balance sheet & scale

IncomeN/A
Revenue$77.6M
Cash$219.1M
Debt$117.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $292.4M

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,410.99 -0.46%
JNJ Johnson & Johnson $270.56 -0.97%
ABBV AbbVie, Inc. $288.84 -2.05%
MRK Merck & Co., Inc. $148.36 -0.78%
RHHBY Roche Holding Ltd Sponsored ADR $60.67 -0.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.